Donna Hamill
Primary Care · Grosse Pointe, MINPI 1992108641
Payments from drug & device makers
Across 494 payments — averaging $33.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Zealand Pharma US, Inc.$2K
- Lilly USA, LLC$1K
- Medtronic$1K
- Sanofi-aventis U.S. LLC$1K
- Abbott$1K
- plus $8K from 46 others
What the payments were for
- Speaking & faculty fees$1,60010%
- Food & beverage$14,89290%
- Education$280%
- Other$500%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEGALOGUE$1,600
- Wegovy$466
- FREESTYLE LIBRE 3$465
- MINIMED 780G$429
- DEXCOM G6 TRANSMITTER$410
- MOUNJARO$358
- JATENZO$352
- EVENITY$270
- TZIELD$256
- FARXIGA$252
- AFREZZA$237
- Kerendia$229
- CeQur Simplicity$183
- FreeStyle Libre$136
- INTELLIS ADAPTIVESTIM$132
- NOCDURNA$132
- XYOSTED$132
- TLANDO$132
- INPEN SMART INSULIN DELIVERY SYSTEM$128
- JARDIANCE$124
How this compares
$16,570 in reported general payments places this provider in the 95th percentile of 292 primary care providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 309 | $477,875 |
| OzempicSemaglutide | 176 | $322,754 |
| JardianceEmpagliflozin | 155 | $201,366 |
| Tresiba Flextouch U-200Insulin Degludec | 51 | $104,679 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 65 | $98,359 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 57 | $82,792 |
| TrulicityDulaglutide | 49 | $79,034 |
| FarxigaDapagliflozin Propanediol | 63 | $74,801 |
| Humalog Kwikpen U-200Insulin Lispro | 24 | $54,409 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 26 | $44,008 |
| SynjardyEmpagliflozin/Metformin Hcl | 25 | $31,813 |
| Novolog FlexpenInsulin Aspart | 83 | $31,535 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 130 | $26,853 |
| Humulin R U-500Insulin Regular, Human | 14 | $24,833 |
| NovologInsulin Aspart | 58 | $23,808 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,424 | $580,041424 claims |
| Novo NordiskOzempic, Novolog | $1,825 | $346,562234 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $601 | $277,188206 claims |
| AstraZenecaFarxiga | $614 | $74,80163 claims |
| Johnson & JohnsonInvokana | $23 | $12,89918 claims |
| Sanofi-aventis U.S. LLCLantus | $1,206 | $2,46512 claims |
| AbbVieSynthroid | $181 | $1,27018 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $223 | $76366 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 292 primary care providers in Michigan.
Other primary care in Grosse Pointe
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
- Katherine HouleMarquette$7K
- Susan ArmstrongWyandotte$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.